Show Notes

Well, according to the Mayo Clinic, Mild Cognitive Impairment is a state of cognitive decline that is the in-between stage between typical cognition and dementia. Most people with MCI are aware of their memory and mental ability decline. At this stage, family and close friends also tend to notice changes. But the decline isn’t severe enough to prevent the affected person’s carrying out of most of their activities of daily living.

A person with mild cognitive impairment can remain at this level of impairment for years, getting by with compensating strategies and the help of family. But about 15% of people with MCI go on develop Dementia within two years. Within 5 years, about 30% of people with MCI get diagnosed with dementia, and within 10 years about 50% of people with MCI go on to develop dementia, primarily Alzheimer’s Disease dementia.

Reversal of Cognitive Decline: A Novel Therapeutic Approach 2014 study: https://pmc.ncbi.nlm.nih.gov/articles/PMC4221920/

Reversal of Cognitive Decline 2016 study: https://pmc.ncbi.nlm.nih.gov/articles/PMC4931830/

Reversal of Cognitive Decline: 100 Patients 2018 study: https://www.coastalmedicine.com/assets/silver_websites/coastal-neurotherapy/pdf/Bredesen_Hagedorn_et_al_2018_J_of_Alz_Disease.pdf

Precision Medicine Approach to Alzheimer’s Disease: Successful Pilot Project 2022 study: https://content.iospress.com/articles/journal-of-alzheimers-disease/jad215707

Dr. Bredesen’s website: https://www.apollohealthco.com/

Looking for Answers: The Bredesen Protocol Ep. 002: https://www.youtube.com/watch?v=VUk_dLuDKgk&t=126s

Ep.088. Edited by Josh Rodriguez.

#alzheimers #mildcognitiveimpairment

In this video, learn the distinction between mild cognitive impairment and Alzheimer’s disease from the perspective of a dedicated caregiver. Discover the potential of the Bredesen Protocol to address cognitive decline. Gain valuable insights on managing Alzheimer’s disease and potentially reversing its effects.